Australia markets closed

Health Catalyst, Inc. (HCAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.39+0.34 (+5.62%)
At close: 04:00PM EDT
6.39 0.00 (0.00%)
After hours: 04:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 377.23M
Enterprise value 298.32M
Trailing P/E 14.16
Forward P/E 20.28
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.27
Price/book (mrq)1.06
Enterprise value/revenue 1.01
Enterprise value/EBITDA -27.72

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3-47.71%
S&P500 52-week change 322.55%
52-week high 314.37
52-week low 35.45
50-day moving average 36.43
200-day moving average 38.04

Share statistics

Avg vol (3-month) 3603.25k
Avg vol (10-day) 3549.78k
Shares outstanding 559.03M
Implied shares outstanding 659.03M
Float 857.44M
% held by insiders 13.18%
% held by institutions 189.03%
Shares short (14 June 2024) 41.89M
Short ratio (14 June 2024) 43.79
Short % of float (14 June 2024) 43.26%
Short % of shares outstanding (14 June 2024) 43.20%
Shares short (prior month 15 May 2024) 42.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -35.56%
Operating margin (ttm)-24.07%

Management effectiveness

Return on assets (ttm)-7.27%
Return on equity (ttm)-27.69%

Income statement

Revenue (ttm)296.79M
Revenue per share (ttm)5.19
Quarterly revenue growth (yoy)1.20%
Gross profit (ttm)N/A
EBITDA -51.18M
Net income avi to common (ttm)-105.54M
Diluted EPS (ttm)-1.84
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)327.78M
Total cash per share (mrq)5.55
Total debt (mrq)248.87M
Total debt/equity (mrq)69.67%
Current ratio (mrq)4.31
Book value per share (mrq)6.06

Cash flow statement

Operating cash flow (ttm)-17.23M
Levered free cash flow (ttm)23.02M